Tower Research Capital LLC TRC Purchases 5,825 Shares of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Tower Research Capital LLC TRC raised its stake in Apollo Medical Holdings, Inc. (NASDAQ:AMEH – Get Rating) by 308.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,714 shares of the company’s stock after purchasing an additional 5,825 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Apollo Medical were worth $301,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the stock. UBS Group AG bought a new position in Apollo Medical in the third quarter valued at approximately $52,000. Amalgamated Bank grew its stake in Apollo Medical by 2.9% in the third quarter. Amalgamated Bank now owns 19,004 shares of the company’s stock valued at $741,000 after purchasing an additional 533 shares in the last quarter. Mutual of America Capital Management LLC grew its stake in Apollo Medical by 21.9% in the third quarter. Mutual of America Capital Management LLC now owns 7,805 shares of the company’s stock valued at $304,000 after purchasing an additional 1,404 shares in the last quarter. Virtu Financial LLC bought a new position in shares of Apollo Medical during the 3rd quarter worth approximately $314,000. Finally, Quantbot Technologies LP boosted its stake in shares of Apollo Medical by 1,575.0% during the 3rd quarter. Quantbot Technologies LP now owns 23,685 shares of the company’s stock worth $923,000 after acquiring an additional 22,271 shares during the period. 34.91% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital lifted their target price on Apollo Medical from $40.00 to $60.00 and gave the stock a “buy” rating in a research note on Monday. One investment analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $58.50.

Apollo Medical Stock Performance

Shares of NASDAQ AMEH opened at $36.51 on Thursday. The company has a current ratio of 2.95, a quick ratio of 2.84 and a debt-to-equity ratio of 0.37. Apollo Medical Holdings, Inc. has a 12 month low of $26.89 and a 12 month high of $58.00. The stock has a 50 day moving average of $33.24 and a 200-day moving average of $35.18. The company has a market capitalization of $2.07 billion, a P/E ratio of 34.44 and a beta of 0.74.

About Apollo Medical

(Get Rating)

Apollo Medical Holdings, Inc is a physician-centric, technology-powered, risk-bearing healthcare management company. It focuses on providing population health management and healthcare delivery platform. The company operates as an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner.